Wnt/ß-Catenin Signalling and Its Cofactor BCL9L Have an Oncogenic Effect in Bladder Cancer Cells.

Kotolloshi, Roland; Gajda, Mieczyslaw; Grimm, Marc-Oliver; Steinbach, Daniel

Kotolloshi, Roland; Gajda, Mieczyslaw; Grimm, Marc-Oliver; Steinbach, Daniel.

Affiliation

Kotolloshi R; Department of Urology, Jena University Hospital, 07747 Jena, Germany.
Gajda M; Section of Pathology, Department of Forensic Medicine, Jena University Hospital, 07747 Jena, Germany.
Grimm MO; Department of Urology, Jena University Hospital, 07747 Jena, Germany.
Steinbach D; Department of Urology, Jena University Hospital, 07747 Jena, Germany.

Int J Mol Sci ; 23(10)2022 May 10.

Article in En | MEDLINE | ID: mdl-35628130

Subject(s)

DNA-Binding Proteins; Transcription Factors; Urinary Bladder Neoplasms; Wnt Signaling Pathway; Carcinogenesis; DNA-Binding Proteins/metabolism; Humans; RNA, Messenger; Transcription Factors/metabolism; Untranslated Regions; Urinary Bladder Neoplasms/metabolism; beta Catenin/metabolism

Key words

BCL9L; UTR mutation; Wnt Wnt/ß-catenin signalling; bladder cancer; cancer progression

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Transcription Factors / Urinary Bladder Neoplasms / DNA-Binding Proteins / Wnt Signaling Pathway Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google